Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Transient FY26 For Syngene But Momentum In China +1 Projects

May 02 2025

• By Anju Ghangurde

Supply Chain — Syngene reaps gains of China +1 rebalancing (Shutterstock)

Related Content

Novartis Development Head On The India Hub, AI And Not Doing ‘Me Too’ Stuff In Obesity

Feb 20 2025

What India’s Digital Personal Data Protection Norms May Mean For Clinical Trials, Big Pharma GCCs

Feb 04 2025

Trends To Track In India: Deals, Big Pharma GCC Strategy And CAR-Ts In Motion

Jan 17 2025

What’s Driving Growing Optimism About India In Pharma Boardrooms

Dec 10 2024

Related Companies

Syngene International Ltd.

Additional Topics

Supply Chain CRO Manufacturing Sales & Earnings India China

More from India

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window